LONG-TERM DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST TWO YEARS OF THE FREEDOM TRIAL EXTENSION

被引：0
|
作者：
Bone, H. [1 ]
Chapurlat, R. [2 ]
Brandi, M. [3 ]
Brown, J. [6 ]
Czerwinski, E. [4 ]
Daizadeh, N. [5 ]
Grauer, A. [5 ]
Krieg, M. [6 ]
Man, Z. [7 ]
Mellstrom, D. [8 ]
Radominski, S. [9 ]
Reginster, J. [10 ]
Resch, H. [11 ]
Roman, J. [12 ]
Roux, C. [13 ]
Cummings, S. [14 ]
Libanati, C. [8 ]
Papapoulos, S. [15 ]
Thiebaud, D. [16 ]
机构：
[1] Michigan Bone & Mineral Clin, Detroit, MI 91320 USA
[2] Hop Edouard Herriot, Lyon, France
[3] Univ Florence, Florence, Italy
[4] Krakow Med Ctr, BR-80060000 Krakow, Poland
[5] Amgen Inc, Thousand Oaks, CA USA
[6] Univ Lausanne Hosp, Lausanne, Switzerland
[7] Ctr TIEMPO, Buenos Aires, DF, Argentina
[8] Sahlgrens Univ Hosp, Gothenburg, Sweden
[9] Univ Fed Parana, Curitiba, Parana, Brazil
[10] Univ Liege, Liege, Belgium
[11] St Vincents Hosp, Vienna, Austria
[12] Hosp Univ La Fe, Valencia, Spain
[13] Paris Descartes Univ, Paris, France
[14] San Francisco Coordinating Ctr, CPMC Res Inst, San Francisco, CA USA
[15] Leiden Univ, Med Ctr, Leiden, Netherlands
[16] Amgen Australia Pty Ltd, Sydney, NSW, Australia
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
22
引用
收藏
页码：S527 / S528
页数：2
相关论文
共 50 条
  • [21] The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension
    Bone, Henry G.
    Chapurlat, Roland
    Brandi, Maria-Luisa
    Brown, Jacques P.
    Czerwinski, Edward
    Krieg, Marc-Antoine
    Mellstrom, Dan
    Radominski, Sebastiao C.
    Reginster, Jean-Yves
    Resch, Heinrich
    Roman Ivorra, Jose A.
    Roux, Christian
    Vittinghoff, Eric
    Daizadeh, Nadia S.
    Wang, Andrea
    Bradley, Michelle N.
    Franchimont, Nathalie
    Geller, Michelle L.
    Wagman, Rachel B.
    Cummings, Steven R.
    Papapoulos, Socrates
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (11): : 4483 - 4492
  • [22] 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
    Bone, Henry G.
    Wagman, Rachel B.
    Brandi, Maria L.
    Brown, Jacques P.
    Chapurlat, Roland
    Cummings, Steven R.
    Czerwinski, Edward
    Fahrleitner-Pammer, Astrid
    Kendler, David L.
    Lippuner, Kurt
    Reginster, Jean-Yves
    Roux, Christian
    Malouf, Jorge
    Bradley, Michelle N.
    Daizadeh, Nadia S.
    Wang, Andrea
    Dakin, Paula
    Pannacciulli, Nicola
    Dempster, David W.
    Papapoulos, Socrates
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (07): : 513 - 523
  • [23] DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS FOR UP TO 9 YEARS: RESULTS THROUGH YEAR 6 OF THE FREEDOM EXTENSION
    Papapoulos, S.
    Roux, C.
    Bone, H. G.
    Dakin, P.
    Czerwinski, E.
    Frey, D.
    Kendler, D.
    Lewiecki, E. M.
    Malouf, J.
    Mellstrom, D.
    Reginster, J. Y.
    Resch, H.
    Daizadeh, N. S.
    Wang, A.
    Gavin, M.
    Wagman, R. B.
    Brandi, M. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 529 - 530
  • [24] DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS FOR UP TO 9 YEARS: RESULTS THROUGH YEAR 6 OF THE FREEDOM EXTENSION
    Papapoulos, S.
    Roux, C.
    Bone, H. G.
    Dakin, P.
    Czerwinski, E.
    Frey, D.
    Kendler, D.
    Lewiecki, E. M.
    Malouf, J.
    Mellstrom, D.
    Reginster, J. -Y.
    Resch, H.
    Daizadeh, N. S.
    Wang, A.
    Gavin, M.
    Wagman, R. B.
    Brandi, M. L.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S37 - S39
  • [25] Effect of Denosumab Treatment in Postmenopausal Women with Osteoporosis: Eight-Year Results from the Freedom Extension, Phase 3 Clinical Trial
    Lewiecki, E. Michael
    Papapoulos, Socrates
    Lippuner, Kurt
    Roux, Christian
    Lin, Celia J. F.
    Kendler, David L.
    Brandi, Maria L.
    Czerwinski, Edward
    Franek, Edward
    Lakatos, Peter
    Minisola, Salvatore
    Reginster, Jean-Yves
    Jensen, Soren
    Daizadeh, Nadia
    Wang, Andrea
    Gavin, Mary
    Wagman, Rachel B.
    Bone, Henry G.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [26] Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing Results from the FREEDOM Trial
    Adami, Silvano
    Libanati, Cesar
    Boonen, Steven
    Cummings, Steven R.
    Ho, Pei-Ran
    Wang, Andrea
    Siris, Ethel
    Lane, Joseph
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2012, 94A (23): : 2113 - 2119
  • [27] LONG-TERM EFFICACY AND SAFETY OF DENOSUMAB IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
    Papapoulos, S. E.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 411 - 412
  • [28] Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension
    Ferrari, Serge
    Eastell, Richard
    Napoli, Nicola
    Schwartz, Ann
    Hofbauer, Lorenz C.
    Chines, Arkadi
    Wang, Andrea
    Pannacciulli, Nico
    Cummings, Steven R.
    BONE, 2020, 134
  • [29] Low Fracture Incidence Is Maintained in Postmenopausal Women ≥75 Years with Osteoporosis with Long-Term Denosumab Treatment.
    Papapoulos, Socrates
    McClung, Michael R.
    Franchimont, Nathalie
    Adachi, Jonathan D.
    Bone, Henry G.
    Benhamou, Claude-Laurent
    Farrerons, Jordi
    Gallagher, J. C.
    Halse, Johan
    Lippuner, Kurt
    Minisola, Salvatore
    Toerring, Ove
    Daizadeh, Nadia
    Wang, Andrea
    Wagman, Rachel B.
    Boonen, Steven
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S830 - S831
  • [30] Low incidence of fracture maintained with long-term denosumab treatment in women aged ≥75 years with postmenopausal osteoporosis
    Papapoulos, S.
    McClung, M. R.
    Ranchimont, N.
    Adachi, J. D.
    Bone, H. G.
    Benhamou, C. L.
    Farrerons, J.
    Halse, J.
    Lippuner, K.
    Man, Z.
    Minisola, S.
    Torring, O.
    Daizadeh, N.
    Wang, A.
    Wagman, R. B.
    Boonen, S.
    AUSTRALASIAN JOURNAL ON AGEING, 2013, 32 : 23 - 23
12345